These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 34283934)
1. Risk of Obesity Among Children Prescribed Atypical Antipsychotics for Six Months or More. Guber KM; Cortes ND; Duan L J Child Adolesc Psychopharmacol; 2022 Feb; 32(1):52-60. PubMed ID: 34283934 [No Abstract] [Full Text] [Related]
2. [Metabolic side effects of risperidone in early onset schizophrenia]. Goeb JL; Marco S; Duhamel A; Kechid G; Bordet R; Thomas P; Delion P; Jardri R Encephale; 2010 Jun; 36(3):242-52. PubMed ID: 20620267 [TBL] [Abstract][Full Text] [Related]
3. Concomitant Use of Atypical Antipsychotics With Other Psychotropic Medication Classes and the Risk of Type 2 Diabetes Mellitus. Burcu M; Zito JM; Safer DJ; Magder LS; dosReis S; Shaya FT; Rosenthal GL J Am Acad Child Adolesc Psychiatry; 2017 Aug; 56(8):642-651. PubMed ID: 28735693 [TBL] [Abstract][Full Text] [Related]
4. Risperidone versus aripiprazole fracture risk in children and adolescents with autism spectrum disorders. Houghton R; van den Bergh J; Law K; Liu Y; de Vries F Autism Res; 2021 Aug; 14(8):1800-1814. PubMed ID: 34080319 [TBL] [Abstract][Full Text] [Related]
5. Weight-Change Trajectories of Pediatric Outpatients Treated with Risperidone or Aripiprazole in a Naturalistic Setting. Pozzi M; Pisano S; Marano G; Carnovale C; Bravaccio C; Rafaniello C; Capuano A; Rossi F; Rizzo R; Bernardini R; Nobile M; Molteni M; Clementi E; Biganzoli E; Radice S J Child Adolesc Psychopharmacol; 2019 Mar; 29(2):133-140. PubMed ID: 30452281 [TBL] [Abstract][Full Text] [Related]
6. No Differences in Weight Gain Between Risperidone and Aripiprazole in Children and Adolescents After 12 Months. Schoemakers RJ; van Kesteren C; van Rosmalen J; Eussen MLJM; Dieleman HG; Beex-Oosterhuis MM J Child Adolesc Psychopharmacol; 2019 Apr; 29(3):192-196. PubMed ID: 30672720 [TBL] [Abstract][Full Text] [Related]
7. Atypical antipsychotic initiation and the risk of type II diabetes in children and adolescents. Sohn M; Talbert J; Blumenschein K; Moga DC Pharmacoepidemiol Drug Saf; 2015 Jun; 24(6):583-91. PubMed ID: 25808613 [TBL] [Abstract][Full Text] [Related]
8. Cardiovascular Events Following Treatment Initiation with Atypical Antipsychotic Medications in Publicly Insured U.S. Youth. Burcu M; Zito JM; Safer DJ; Magder LS; dosReis S; Shaya FT; Rosenthal GL J Child Adolesc Psychopharmacol; 2018 Sep; 28(7):445-453. PubMed ID: 29975555 [TBL] [Abstract][Full Text] [Related]
9. Use and tolerability of newer antipsychotics and antidepressants: a chart review in a paediatric setting. Alacqua M; Trifirò G; Arcoraci V; Germanò E; Magazù A; Calarese T; Di Vita G; Gagliano C; Spina E Pharm World Sci; 2008 Jan; 30(1):44-50. PubMed ID: 17588130 [TBL] [Abstract][Full Text] [Related]
10. Persistence in Therapy With Risperidone and Aripiprazole in Pediatric Outpatients: A 2-Year Naturalistic Comparison. Pozzi M; Pisano S; Bertella S; Capuano A; Rizzo R; Antoniazzi S; Auricchio F; Carnovale C; Cattaneo D; Ferrajolo C; Gentili M; Guastella G; Mani E; Rafaniello C; Riccio MP; Scuderi MG; Sperandeo S; Sportiello L; Villa L; Radice S; Clementi E; Rossi F; Pascotto A; Bernardini R; Molteni M; Bravaccio C J Clin Psychiatry; 2016 Dec; 77(12):e1601-e1609. PubMed ID: 27780333 [TBL] [Abstract][Full Text] [Related]
11. Risk of Mortality Associated With Atypical Antipsychotic use: A National Cohort Study of Older Adults With Depression and Parkinson's Disease. Chekani F; Holmes HM; Johnson ML; Chen H; Sherer JT; Aparasu RR Am J Geriatr Psychiatry; 2020 Oct; 28(10):1079-1088. PubMed ID: 32147383 [TBL] [Abstract][Full Text] [Related]
12. Feasibility and Relevance of Antipsychotic Safety Monitoring in Children With Tourette Syndrome: A Prospective Longitudinal Study. Pringsheim T; Ho J; Sarna JR; Hammer T; Patten S J Clin Psychopharmacol; 2017 Oct; 37(5):498-504. PubMed ID: 28816926 [TBL] [Abstract][Full Text] [Related]
13. Anticholinergic use in children and adolescents after initiation of antipsychotic therapy. Hong IS; Bishop JR Ann Pharmacother; 2010; 44(7-8):1171-80. PubMed ID: 20587746 [TBL] [Abstract][Full Text] [Related]
14. Antipsychotic Prescribing and Safety Monitoring Practices in Children and Youth: A Population-Based Study in Alberta, Canada. Chen W; Cepoiu-Martin M; Stang A; Duncan D; Symonds C; Cooke L; Pringsheim T Clin Drug Investig; 2018 May; 38(5):449-455. PubMed ID: 29453686 [TBL] [Abstract][Full Text] [Related]
15. Comparison of longer-term safety and effectiveness of 4 atypical antipsychotics in patients over age 40: a trial using equipoise-stratified randomization. Jin H; Shih PA; Golshan S; Mudaliar S; Henry R; Glorioso DK; Arndt S; Kraemer HC; Jeste DV J Clin Psychiatry; 2013 Jan; 74(1):10-8. PubMed ID: 23218100 [TBL] [Abstract][Full Text] [Related]
16. Atypical Antipsychotics and the Risk of Hyperlipidemia: A Sequence Symmetry Analysis. Takeuchi Y; Kajiyama K; Ishiguro C; Uyama Y Drug Saf; 2015 Jul; 38(7):641-50. PubMed ID: 26001933 [TBL] [Abstract][Full Text] [Related]
17. Incidence and predictors of acute akathisia in severely ill patients with first-episode schizophrenia treated with aripiprazole or risperidone: secondary analysis of an observational study. Yoshimura B; Sato K; Sakamoto S; Tsukahara M; Yoshimura Y; So R Psychopharmacology (Berl); 2019 Feb; 236(2):723-730. PubMed ID: 30443794 [TBL] [Abstract][Full Text] [Related]
18. Outpatient treatment of children and adolescents with antipsychotic drugs in Croatia. Maršanić VB; Dodig-Ćurković K; Juretić Z Nord J Psychiatry; 2012 Feb; 66(1):2-7. PubMed ID: 21306199 [TBL] [Abstract][Full Text] [Related]
19. [Use of atypical antipsychotics in Charles Perrens psychiatric hospital (Bordeaux) analysis of prescribing practices for Amisulpride, Clozapine, Olanzapine and Risperidone]. Bret P; Bonnet F; Bret MC; Jaffré A Encephale; 2002; 28(4):329-42. PubMed ID: 12232542 [TBL] [Abstract][Full Text] [Related]
20. Treatment Patterns, Health Care Resource Utilization, and Health Care Cost Associated with Atypical Antipsychotics or Guanfacine Extended Release in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder in Quebec, Canada. Lachaine J; Ben Amor L; Pringsheim T; Burns J; van Stralen J J Child Adolesc Psychopharmacol; 2019 Dec; 29(10):730-739. PubMed ID: 31433205 [No Abstract] [Full Text] [Related] [Next] [New Search]